Anebulo Pharmaceuticals, Inc. (ANEB)
NASDAQ: ANEB · Real-Time Price · USD
2.200
+0.450 (25.71%)
Jul 2, 2025, 4:00 PM - Market closed
Anebulo Pharmaceuticals Market Cap
Anebulo Pharmaceuticals has a market cap or net worth of $74.36 million as of July 3, 2025. Its market cap has increased by 35.26% in one year.
Market Cap
74.36M
Enterprise Value
61.08M
1-Year Change
35.26%
Ranking
Category
Stock Price
$2.20
Market Cap Chart
Since the IPO on May 7, 2021, Anebulo Pharmaceuticals's market cap has decreased from $162.86M to $74.36M, a decrease of -54.34%. That is a compound annual growth rate of -17.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 2, 2025 | 74.36M | 70.68% |
| Dec 31, 2024 | 43.57M | -29.77% |
| Dec 29, 2023 | 62.03M | -0.15% |
| Dec 30, 2022 | 62.13M | -56.73% |
| Dec 29, 2021 | 143.57M | -11.85% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 699.59B |
| Johnson & Johnson | 374.29B |
| AbbVie | 336.94B |
| Novo Nordisk | 309.43B |
| UnitedHealth Group | 279.00B |
| Novartis AG | 243.28B |
| Abbott Laboratories | 233.33B |
| AstraZeneca | 219.33B |